We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M Turnover 16.91%
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+9.68%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$9.62M
Cap. Flow
+$2.42M
Cap. Flow %
1.74%
Top 10 Hldgs %
27.84%
Holding
157
New
14
Increased
39
Reduced
52
Closed
19
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$2.49M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.34M
3
GM icon
GEN MOTORS CORP
GM
+$2.05M
4
PCYC
PHARMACYCLICS INC
PCYC
+$1.37M
5
META icon
Meta Platforms (Facebook)
META
+$1.07M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$1.98M
2
HHH icon
Howard Hughes
HHH
+$1.7M
3
DNY
DONNELLEY R R & SONS CO
DNY
+$1.39M
4
NEM icon
Newmont
NEM
+$860K
5
GLW icon
Corning
GLW
+$834K

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.67%
2 Energy 14.21%
3 Technology 10.78%
4 Healthcare 9.81%
5 Consumer Discretionary 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SVU
126
DELISTED
SUPERVALU Inc.
SVU
– –
-1,429
Closed -$62K –
MPZ
127
DELISTED
MPC CORPORATION COM
MPZ
$0 ﹤0.01%
25,000
– –
2013 Q2
1 quarter
GNH
128
DELISTED
GLOBAL ENERGY HOLDINGS GROUP INC COM STK
GNH
$0 ﹤0.01%
83,558
-1,000
-1% –
2013 Q2
1 quarter
DNY
129
DELISTED
DONNELLEY R R & SONS CO
DNY
– –
-99,000
Closed -$1.39M –
2 3 4 5
6

Similar funds

OIMU
Orbis Investment Management (US) San Francisco, California $99.7M AUM 17.51% 1-Year Est. Return
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
DCM
Diag Capital Management New York $87.4M AUM
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
CFA
Clarfeld Financial Advisors Tarrytown, New York $120M AUM
BPV
Battery Partners VIII Boston, Massachusetts $121M AUM 101.35% 1-Year Est. Return

Benchmark Capital Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Benchmark Capital Advisors held 157 positions worth $139M, up 7.4% from $130M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Benchmark Capital Advisors's Q3 2013 filing shows 14 new, 39 increased, 52 reduced and 19 closed positions. Its largest new stake was Bristol-Myers Squibb: 53,400 shares worth $2.47M. The largest sale was Ligand Pharmaceuticals, an estimated $1.98M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 24% a quarter earlier, followed by Energy and Technology.

  • Benchmark Capital Advisors's largest Q3 2013 buy was Bristol-Myers Squibb: 53,400 shares worth $2.47M.
  • Benchmark Capital Advisors added most to Vodafone in Q3 2013, an estimated $2.49M increase.
  • Benchmark Capital Advisors's biggest Q3 2013 reduction was Howard Hughes, cutting an estimated $1.7M.
  • Benchmark Capital Advisors fully exited Ligand Pharmaceuticals in Q3 2013, selling an estimated $1.98M.
  • Benchmark Capital Advisors's ten largest holdings make up 28% of its $139M portfolio in Q3 2013.
  • Benchmark Capital Advisors opened 14 new positions and closed 19 in Q3 2013.
  • Benchmark Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $139M.

Based on Benchmark Capital Advisors's 13F filing for Q3 2013, filed 23 Oct 2013.